CACTUS ACQUISITION 1 Stock Price, News & Analysis

CCTS NASDAQ

Company Description

Cactus Acquisition Corp. 1 Limited (Nasdaq: CCTS), commonly referred to as Cactus Acquisition, is a blank check company focused on merging with, acquiring, or combining with technology-based healthcare businesses, particularly those with significant ties to Israel. Operating under the strategic leadership of Chairman Nachum (Homi) Shamir, CEO Ofer Gonen, and CFO Stephen T. Wills, the company aims to capitalize on innovative healthcare solutions and technologies emerging from the Israeli market.

Recently, Cactus Acquisition announced an extraordinary general meeting set for November 2, 2023, to vote on extending the deadline to complete a business combination. If approved, this Extension will push the current termination date from November 2, 2023, to November 2, 2024. As part of this process, the company's sponsor, Cactus Healthcare Management LP, plans to make monthly contributions to the trust account, ensuring that shareholders' investments remain secure during this period.

Cactus Acquisition's strategy involves leveraging the high growth potential of Israeli technology-based healthcare companies. By focusing on this niche market, they aim to bring advanced healthcare solutions to a global audience. The company’s proactive approach includes not only identifying potential business combinations but also ensuring financial stability and compliance with regulatory requirements.

The firm’s commitment to maintaining trust funds in interest-bearing accounts demonstrates a prudent financial strategy, aimed at maximizing returns for shareholders. Additionally, they have confirmed their intention not to use trust funds to cover potential excise taxes, emphasizing their focus on safeguarding investor interests.

With a clear vision and robust financial strategies, Cactus Acquisition Corp. 1 Limited is well-positioned to navigate the complex landscape of mergers and acquisitions in the healthcare sector. Investors can look forward to detailed updates as the company progresses towards achieving its strategic goals.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

20.42 %

Performance 1 year

$56.9M

Market Cap

5.1M

Shares outstanding

Latest News

View All

October 30, 2023

1.10%

CACTUS ACQUISITION CORP. 1 LIMITED ANNOUNCES CONTRIBUTIONS TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSION

acquisition

April 12, 2023

0.10%

CACTUS ACQUISITION CORP. 1 LTD. ANNOUNCES CONTRIBUTIONS TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSION

acquisition

April 5, 2022

0.20%

Cactus Acquisition Corp. 1 Limited Files its Annual Report for the 2021 Year

acquisition

SEC Filings

View All

No SEC filings available for CACTUS ACQUISITION 1.

Financial Highlights

-$216,000

Net Income (TTM)

$74,000

Operating Cash Flow

0.03

Current Ratio

—

Revenue (TTM)

—

Diluted EPS (TTM)

—

Net Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of CACTUS ACQUISITION 1 (CCTS)?

The current stock price of CACTUS ACQUISITION 1 (CCTS) is $11.21 as of February 7, 2025.

What is the market cap of CACTUS ACQUISITION 1 (CCTS)?

The market cap of CACTUS ACQUISITION 1 (CCTS) is approximately 56.9M.

What is the net income of CACTUS ACQUISITION 1 (CCTS)?

The trailing twelve months (TTM) net income of CACTUS ACQUISITION 1 (CCTS) is -$216,000.

What is the operating cash flow of CACTUS ACQUISITION 1 (CCTS)?

The operating cash flow of CACTUS ACQUISITION 1 (CCTS) is $74,000.

What is the current ratio of CACTUS ACQUISITION 1 (CCTS)?

The current ratio of CACTUS ACQUISITION 1 (CCTS) is 0.03, indicating the company's ability to pay short-term obligations.

What is Cactus Acquisition Corp. 1 Limited?

Cactus Acquisition Corp. 1 Limited is a blank check company focusing on merging with or acquiring technology-based healthcare businesses, particularly those with significant ties to Israel.

Who leads Cactus Acquisition Corp. 1 Limited?

The company is led by Chairman Nachum (Homi) Shamir, CEO Ofer Gonen, and CFO Stephen T. Wills.

What is the purpose of the upcoming meeting on November 2, 2023?

The meeting will vote on extending the deadline to complete a business combination from November 2, 2023, to November 2, 2024.

What will happen if the Extension is approved?

If approved, Cactus Healthcare Management LP will make monthly contributions to the trust account to ensure the financial stability of the company.

What is the company's strategy?

Cactus Acquisition targets technology-based healthcare companies with significant Israeli connections to bring innovative healthcare solutions to a global market.

Will trust funds be used to pay for excise taxes?

No, the company has confirmed that trust funds will not be used to cover potential excise taxes.

What happens if a contribution is not made on time?

If a contribution is not made, the company will liquidate and dissolve in accordance with its articles of association.

How will the trust funds be managed?

If the Extension is implemented, trust funds will be kept in an interest-bearing account to maximize returns for shareholders.

What is a blank check company?

A blank check company is formed for the purpose of merging with or acquiring other companies, not conducting any operations or generating revenue on its own.

How can I get more information about the meeting and proposals?

Details about the meeting and proposals are available in the Definitive Proxy Statement, which can be accessed through the SEC’s website or requested from the company.